Word

PAION

Status

Dead

Status Code

710

Status Date

Friday, April 7, 2017

Serial Number

78070532

Registration Number

3134824

Registration Date

Tuesday, August 29, 2006

Mark Type

1000

Filing Date

Friday, June 22, 2001

Published for Opposition

Tuesday, June 6, 2006

Cancellation Date

Friday, April 7, 2017

Trademark Owner History

PAION DEUTSCHLAND GMBH -
PAION GmbH - Original Registrant

Classifications

1 (Based on 44(e)) Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use

5 (Based on 44(e)) Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment [ and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, ] nervous diseases, [ diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents; ] medical and clinical diagnostic reagents for clinical or medical laboratory use

10 [ (Based on 44(e)) Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration ]

35 [ (Based on 44(e)) Computerized database management, namely, editing, evaluating and processing data for third parties ]

41 [ (Based on Use in Commerce) Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics ]

42 (Based on 44(e)) [ Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; ] preparation of expert opinions in the field of [ chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, ] product research and development of medical devices and pharmaceutical preparations; [ and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; ] performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; [ bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; ] scientific research on and development of [ medical diagnostic equipment and ] pharmaceutical preparations and products for the treatment of [ tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, ] nervous diseases, [ diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, ] pain [ and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment ]

Color is not claimed as a feature of the mark.
The English translation of the Greek word PAION in the mark is the name of a Greek mythological god.

Trademark Events

Apr 7, 2017

Cancelled Sec. 8 (10-Yr)/Expired Section 9

Aug 29, 2015

Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed

Mar 14, 2013

Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed

Mar 14, 2013

Registered - Partial Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.

Feb 27, 2013

Registered - Sec. 8 (6-Yr) & Sec. 15 Filed

Mar 14, 2013

Case Assigned To Post Registration Paralegal

Feb 27, 2013

Teas Section 8 & 15 Received

Nov 15, 2006

Automatic Update Of Assignment Of Ownership

Aug 29, 2006

Registered-Principal Register

Jun 6, 2006

Published For Opposition

May 17, 2006

Notice Of Publication

Apr 14, 2006

Law Office Publication Review Completed

Apr 7, 2006

Assigned To Lie

Apr 6, 2006

Approved For Pub - Principal Register

Apr 6, 2006

Previous Allowance Count Withdrawn

Apr 6, 2006

Approved For Pub - Principal Register

Apr 6, 2006

Use Amendment Accepted

Mar 28, 2006

Amendment From Applicant Entered

Mar 14, 2006

Correspondence Received In Law Office

Mar 28, 2006

Amendment From Applicant Entered

Mar 9, 2006

Correspondence Received In Law Office

Mar 28, 2006

Amendment To Use Processing Complete

Mar 14, 2006

Use Amendment Filed

Mar 14, 2006

Paper Received

Mar 9, 2006

Paper Received

Jan 30, 2006

Non-Final Action Mailed

Jan 30, 2006

Non-Final Action Written

Jan 30, 2006

Previous Allowance Count Withdrawn

Jan 24, 2006

1(B) Basis Deleted; New Basis Requested

Jan 24, 2006

Notice Of Allowance Cancelled

Dec 22, 2005

Petition To Director - Change Basis - Granted

Nov 18, 2005

Petition To Director - Change Basis - Received

Nov 18, 2005

Paper Received

Sep 15, 2005

Extension 5 Granted

Sep 1, 2005

Extension 5 Filed

Sep 1, 2005

Paper Received

Apr 18, 2005

Extension 4 Granted

Mar 9, 2005

Extension 4 Filed

Mar 9, 2005

Paper Received

Sep 28, 2004

Extension 3 Granted

Sep 8, 2004

Extension 3 Filed

Sep 8, 2004

Paper Received

Aug 11, 2004

Case File In Ticrs

Mar 23, 2004

Extension 2 Granted

Mar 8, 2004

Extension 2 Filed

Mar 8, 2004

Paper Received

Oct 8, 2003

Extension 1 Granted

Sep 9, 2003

Extension 1 Filed

Oct 8, 2003

Divisional Processing Complete

Sep 9, 2003

Divisional Request Received

Sep 9, 2003

Paper Received

Mar 11, 2003

Noa Mailed - Sou Required From Applicant

Dec 17, 2002

Published For Opposition

Nov 27, 2002

Notice Of Publication

Oct 15, 2002

Approved For Pub - Principal Register

Oct 1, 2002

Assigned To Examiner

Aug 22, 2002

Correspondence Received In Law Office

Aug 22, 2002

Paper Received

May 9, 2002

Final Refusal Mailed

Nov 19, 2001

Correspondence Received In Law Office

Sep 17, 2001

Non-Final Action Mailed

Aug 24, 2001

Assigned To Examiner